PAMA Unlocks Golden Age for Innovative Diagnostics

PAMA Unlocks Golden Age for Innovative Diagnostics

By Chance Scott  bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…


. . . read more

PAMA-Geddon: Lab Industry Takes CMS to Court

CMS Ignored Congressional Intent in Implementing New Clinical Lab Payment System Under PAMA, ACLA Charges in Suit

From - G2 Compliance Advisor
The government agency that runs the Medicare program failed to follow a congressional directive to implement a market-based laboratory payment system…


. . . read more

This content is for Paid Members only.
Register
Already a member? Log in here
PAMA Unlocks Golden Age for Innovative Diagnostics

CMS Ignores Flawed Processes, Finalizes 2018 PAMA Pricing; Labs Need to Take Immediate Action to Offset Impending Lean Times

By Kyle Fetter  bio
The final 2018 clinical laboratory fee schedule (CLFS) is out, and it is evident that the argument that the Centers for Medicare & Medicaid Services (CMS) PAMA process was…


. . . read more